• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Pseudoaneurysm (2605)
Event Date 03/11/2020
Event Type  malfunction  
Event Description
On an unknown date in (b)(6) 2019, the patient underwent treatment for vein graft stenosis by performing pta ballooning and implanting a lifestent® vascular and biliary stent (lifestent, 6mm x 80mm).On (b)(6) 2020, the patient underwent treatment for stenosis in the previously implanted lifestent® using a gore® viabahn® endoprosthesis (vsx).The vsx device was placed within the lifestent® with the distal tip of the vsx device landing in the popliteal artery.On (b)(6) 2020 imaging identified the lifestent® had fractured and had torn in half creating a pseudoaneurysm.The vxs device reportedly compressed proximally, exposing the lifestent®.A re-intervention is planned to explant the device and perform a surgical bypass.
 
Manufacturer Narrative
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On an unknown date in(b)(6)2019, the patient underwent treatment for vein graft stenosis by performing pta ballooning and implanting a lifestent® vascular and biliary stent (lifestent, 6mmx80mm).¿ on (b)(6) 2020, the patient underwent treatment for stenosis in the previously implanted lifestent® using a gore® viabahn® endoprosthesis (vsx).The vsx device was placed within the lifestent® with the distal tip of the vsx device landing in the popliteal artery.On (b)(6) 2020 imaging identified the lifestent® had fractured and had torn in half creating a pseudoaneurysm.¿the vxs device reportedly compressed proximally, exposing the lifestent®.¿ no additional information from the account will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10397856
MDR Text Key207334009
Report Number2017233-2020-01118
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/15/2020
Initial Date FDA Received08/12/2020
Supplement Dates Manufacturer Received07/15/2020
Supplement Dates FDA Received12/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-